Hadassah

Hadassah Hospital Senior Oncologist Dr. Asher Salmon Rejects Universal BRCA Gene Home Tests Without Analysis of Family History & Genetic Counseling

Tuesday, May 12 2015

MEDIA INQUIRES CONTACT:
Renee Young, National Public Relations
ryoung@hadassah.org
(212) 303- 8140

National Women’s Health Week (May 10 – 16) Promotes Increased Awareness about Screening for Breast & Ovarian Cancer

“A positive BRCA test does not mean a leap to surgery...”
— ANGELINA JOLIE, NY TIMES 03/24/15



New York, NY – May 11, 2015 – Dr. Asher Salmon, Oncologist & Deputy Director, Hadassah Hospital Ein Kerem, Jerusalem publically renounces universal BRCA testing for women starting at age 30. His comment is in response to a new home testing kit endorsed by Genetics Researcher Dr. Marie-Claire King of the University of Washington and Color Genomics (NY Times, 4/21/15).  Salmon maintains that the results of BRCA testing alone, without genetic counseling and extensive analysis of family history, do not provide women with the complete picture needed to make an intelligent decision regarding treatment.

According to Dr. Salmon, who also holds a PhD in molecular biology, “30% of women tested will have a gene alteration for which we don’t know the significance, whether it is dangerous or benign, leaving women in a state of uncertainly as to whether they are at risk or not.  By the same token, testing negative for the BRCA mutation does not mean a woman is risk-free for breast cancer and can skip regular mammograms or breast exams. She also needs to continue to take care of herself and choose a healthy lifestyle.”

Hadassah Medical Organization (HMO), Jerusalem has done extensive research with the BRCA gene mutations that significantly increase a woman’s risk of developing breast cancer. The Hadassah Medical Organization discovered Ashkenazi Jewish women have 10 times the frequency of BRCA mutations than non-Ashkenazi women. Approximately one out of every 40 individuals of Ashkenazi Jewish ancestry have a mutation in the BRCA1 or BRCA2 gene, as compared to one out of every 800 members of the general population, according to The Center for Disease Control.

In 2013, Israeli researchers, led by Dr. Salmon, developed Gene Expression Profiling, a blood test that predicts the presence of harmful BRCA1 and BRCA2 mutations in otherwise healthy women. Women with a mutation in their BRCA1 or BRCA2 gene have an increased risk for developing breast or ovarian cancer. For many of those at risk, the disease may begin at an early age.

According to the National Cancer Institute (NCI), there will be a 50% increase in breast cancer by 2030.

As Angelina Jolie noted in a 3/24/15 NY Times Op-Ed piece regarding her surgery, “I did not do this solely because I carry a BRCA1 gene mutation, and I want other women to hear this. A positive BRCA does not mean a leap to surgery.  In my case…surgery to remove my tubes and ovaries was the best option. On top of the BRCA gene, three women in my family have died of cancer.”

Dr. Salmon emphasizes: "Women with a family history of breast cancer should be tested--maybe as early as age 25--but the majority of women never have to be tested. We shouldn't be practicing one-size-fits-all medicine, but rather medicine with appropriate protocols, guidelines and individualized treatment based on patients’ personal histories.”

HWZOA National President Marcie Natan, a breast cancer survivor who tested negative for the BRCA gene, notes: “HWZOA has always been in the vanguard of empowering women with knowledge and information to be proactive regarding their health and wellness. National Women’s Health Week (May 10 – 16) is an ideal opportunity to focus on your own health and choose a healthy lifestyle.”

###

Hadassah is the largest Jewish women’s organization in the United States. With 330,000 members, associates and supporters across the country, Hadassah brings Jewish women together to effect change and advocate on criticalissues such as medical care and research, women's empowerment, and the security of Israel. Through the Hadassah Medical Organization's (HMO) two hospitals, the world-renowned trauma center and the leading research facility in Jerusalem, Hadassah supports the delivery of exemplary patient care to over a million people every year. HMO serves without regard to race, religion or nationality and earned a Nobel Peace Prize Nomination in 2005 for building “bridges to peace” through equality in medical treatment. For more information, visit www.hadassah.org.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Aug 14 2018

Hadassah Hospital Helps Educate Mikvah Attendants To Bolster Women’s Health

After a woman emerges from the ritual bath (mikveh) and wraps herself in a towel, says mikveh attendant Daniella Salomon, “I keep an eye out” for anything unusual.

READ MORE ›
alt_text

Tuesday, Aug 7 2018

American Medical Attaché and Consulate Nurse Tour Hadassah Hospital Ein Kerem

Jennifer Kmiecinski, Medical Attaché to the Consulate General of the United States in Israel, visited Hadassah Hospital Ein Kerem earlier this month to assess the level of health care available to American personnel serving in Israel.

READ MORE ›
alt_text

Thursday, Aug 2 2018

Thyroid Cancer Diagnosis Enhanced at Hadassah Using Advanced Gene Sequencing

Hadassah Medical Organization researchers, using next generation sequencing (NGS), have identified a highly accurate RNA panel that distinguishes thyroid cancer from benign nodules.

READ MORE ›
alt_text

Thursday, Aug 2 2018

Two Hadassah Ophthalmology Articles Are Among Top 100 Most Cited in Four Decades

Two articles by Hadassah Medical Organization ophthalmologists are among the 100 most cited ophthalmology articles from 1975-2017. One is ranked 11th.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More